by John Conrad | Jul 29, 2024 | iBIO in the News
GEN Releases 2024 Top Biopharma Clusters: Chicago Climbs to 9th Place Genetic Engineering & Biotechnology News (GEN) has unveiled its annual list of top biopharma clusters for 2024, with Chicago making a notable ascent in the rankings. The Windy City has moved up...
by John Conrad | Jul 25, 2024 | iBIO News
We’re trying something new! Welcome to the first NewsBrief Innovation Insider Interview, where we chat with leaders from the biotech, pharma, medtech, venture capital and science community and explore cutting-edge ideas and strategies to help you gain actionable...
by John Conrad | Jul 24, 2024 | NewsBrief
The University of Chicago’s Polsky Center for Entrepreneurship and Innovation has forged a strategic partnership with Orange Grove Bio (OGB), an integrated biopharmaceutical company, in a move set to accelerate biotech innovation and commercialization. This...
by John Conrad | Jul 19, 2024 | NewsBrief
In a strategic move to expand its specialty biopharmaceuticals portfolio, Meitheal Pharmaceuticals has acquired the North American rights to CONTEPO™ (fosfomycin for injection) from Nabriva Therapeutics. The announcement, made on July 18, 2024, marks a significant...
by John Conrad | Jul 8, 2024 | NewsBrief
The heart of Illinois is set to become a global leader in biomanufacturing, thanks to a significant $51 million federal grant awarded to the Illinois Fermentation and Agriculture Biomanufacturing (iFAB) Tech Hub. This exciting development promises to transform the...
